Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Summary

Orchestra BioMed Holdings (Nasdaq: OBIO) announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York, NY from December 3-5, 2024. The company's management will deliver a fireside chat presentation on Wednesday, December 4, 2024, at 3:00 PM EST. The presentation will be available via webcast, with a replay accessible on the Orchestra BioMed website's Events section for 90 days afterward. The company will also be available for one-on-one meetings during the conference.

NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will present and be available for one-on-one meetings at the Piper Sandler 36^th Annual Healthcare Conference being held in New York, NY from December 3-5, 2024.

Details of the presentation are shown below.

Format: Fireside Chat
Date: Wednesday, December 4, 2024
Time: 3:00 PM EST
Webcast: https://event.webcasts.com/starthere.jsp?ei=1700018&tp_key=660c0503d6

A replay of the webcast will be available on the Events section of the Orchestra BioMed website for 90 days following the presentation.

About Orchestra BioMed
Orchestra BioMed (Nasdaq: OBIO) is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. Orchestra BioMed’s lead product candidate is atrioventricular interval modulation (AVIM) therapy (also known as BackBeat Cardiac Neuromodulation Therapy (CNT™)) for the treatment of hypertension, a significant risk factor for death worldwide. Orchestra BioMed is also developing Virtue^® Sirolimus AngioInfusion™ Balloon (SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. Orchestra BioMed has a strategic collaboration with Medtronic, one of the largest medical device companies in the world, for development and commercialization of AVIM therapy for the treatment of hypertension in pacemaker-indicated patients, and a strategic partnership with Terumo, a global leader in medical technology, for development and commercialization of Virtue SAB for the treatment of artery disease. For further information about Orchestra BioMed, please visit www.orchestrabiomed.com, and follow us on LinkedIn.

References to Websites and Social Media Platforms

References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

Contact:
Kelsey Kirk-Ellis
Orchestra BioMed
484-682-4892
Kkirkellis@orchestrabiomed.com

FAQ

When is Orchestra BioMed (OBIO) presenting at the Piper Sandler Healthcare Conference 2024?

Orchestra BioMed (OBIO) is presenting on Wednesday, December 4, 2024, at 3:00 PM EST during the Piper Sandler Healthcare Conference.

How long will Orchestra BioMed's (OBIO) Piper Sandler Conference webcast be available for replay?

The webcast replay will be available on Orchestra BioMed's website Events section for 90 days following the presentation.

What type of presentation will Orchestra BioMed (OBIO) give at the Piper Sandler Conference 2024?

Orchestra BioMed will participate in a fireside chat format presentation at the conference.

Where is the Piper Sandler Healthcare Conference 2024 being held?

The Piper Sandler 36th Annual Healthcare Conference is being held in New York, NY from December 3-5, 2024.